SG/CALL/QIAGEN/50/0.1/20.09.24 Stock

DE000SU7Q394

Real-time Boerse Frankfurt Warrants 09:43:10 2024-07-03 am EDT
0.031 ^EUR	+40.91%

Current month	-21.43%
1 month	-57.69%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart QIAGEN N.V.

Quotes 5-day view

Date	Price	Change
24-07-03	0.031	+40.91%
24-07-02	0.022	+22.22%
24-07-01	0.018	-35.71%
24-06-28	0.028	-3.45%
24-06-27	0.029	+3.57%

Real-time Boerse Frankfurt Warrants

Last update July 03, 2024 at 09:43 am EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	QIAGEN N.V.
Issuer	Société Générale
WKN	SU7Q39
ISIN	DE000SU7Q394
Date issued	2024-02-01
Strike	50 €
Maturity	2024-09-20 (79 Days)
Parity	10 : 1
Emission price	0.12 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.15 €
Lowest since issue	0.016 €

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Sector

More about the company